文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

放射性直肠出血预测模型的验证:来自前列腺癌患者大型汇总人群的证据

Validation of prediction models for radiation-induced late rectal bleeding: Evidence from a large pooled population of prostate cancer patients.
PubMed 文献 · Radiother Oncol · 2023-03-18

该研究在三个前瞻性试验汇总的1633例前列腺癌根治性放疗患者中,外部验证截至2021年发表的16个基于直肠剂量体积直方图等效均匀剂量的正常组织并发症概率模型,预测≥1级、≥2级和3级晚期直肠出血。结果显示严重晚期直肠出血模型性能良好,中等至高剂量直肠体积参数重要,腹部手术和心血管疾病为风险因素。

要点

  • 在1633例前列腺癌放疗患者中验证16个NTCP模型,≥2级和3级晚期直肠出血模型性能良好。
  • 直肠中高剂量体积参数对≥2级(n=0.24)和3级(n=0.18)晚期直肠出血重要。
  • 外部验证队列确认腹部手术和心血管疾病为晚期直肠出血风险因素。

核心结论

  • 五个基于非当代队列开发的已发表NTCP模型能够在较近期验证人群中预测毒性反应的相对增加。
  • 与QUANTEC研究结果相比,剂量学结果指向直肠DVH的中高剂量。
  • 外部验证队列确认腹部手术和心血管疾病为风险因素。

研究设计与样本

  • 外部验证人群包括2003年至2014年间入组的欧洲和大洋洲中心患者。
  • 患者接受3DCRT或IMRT,剂量66-80 Gy;IMRT采用常规或大分割方案(2.35-2.65 Gy/次)。
  • 晚期直肠出血采用患者报告问卷(LENT/SOMA量表)前瞻性评分,随访3年。
  • 验证截至2021年发表的基于直肠DVH等效均匀剂量的所有NTCP模型,通过校准和区分度评估模型性能。

主要发现

  • 在1633例患者数据中测试了16个NTCP模型。
  • ≥1级晚期直肠出血465例(28.5%),≥2级255例(15.6%),3级112例(6.8%)。
  • ≥2级和3级晚期直肠出血的最佳性能突显直肠中高剂量的重要性(体积参数n分别为0.24和0.18)。
  • 严重晚期直肠出血模型表现良好。
  • 包含两个临床因素的多变量模型校准斜率最佳。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To validate published models for the risk estimate of grade ≥ 1 (G1+), grade ≥ 2 (G2+) and grade = 3 (G3) late rectal bleeding (LRB) after radical radiotherapy for prostate cancer in a large pooled population from three prospective trials. MATERIALS AND METHODS: The external validation population included patients from Europe, and Oceanian centres enrolled between 2003 and 2014. Patients received 3DCRT or IMRT at doses between 66-80 Gy. IMRT was administered with conventional or hypofractionated schemes (2.35-2.65 Gy/fr). LRB was prospectively scored using patient-reported questionnaires (LENT/SOMA scale) with a 3-year follow-up. All Normal Tissue Complication Probability (NTCP) models published until 2021 based on the Equivalent Uniform Dose (EUD) from the rectal Dose Volume Histogram (DVH) were considered for validation. Model performance in validation was evaluated through calibration and discrimination. RESULTS: Sixteen NTCP models were tested on data from 1633 patients. G1+ LRB was scored in 465 patients (28.5%), G2+ in 255 patients (15.6%) and G3 in 112 patients (6.8%). The best performances for G2+ and G3 LRB highlighted the importance of the medium-high doses to the rectum (volume parameters n = 0.24 and n = 0.18, respectively). Good performance was seen for models of severe LRB. Moreover, a multivariate model with two clinical factors found the best calibration slope. CONCLUSION: Five published NTCP models developed on non-contemporary cohorts were able to predict a relative increase in the toxicity response in a more recent validation population. Compared to QUANTEC findings, dosimetric results pointed toward mid-high doses of rectal DVH. The external validation cohort confirmed abdominal surgery and cardiovascular diseases as risk factors.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Cicchetti A, Fiorino C, Ebert MA, et al. Validation of prediction models for radiation-induced late rectal bleeding: Evidence from a large pooled population of prostate cancer patients. Radiother Oncol. 2023. PMID: 36934896. doi:10.1016/j.radonc.2023.109628

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。